Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
betamethasone dipropionate
calcipotriol |
| gptkbp:approvedBy |
gptkb:Australia
gptkb:European_Union 2001 |
| gptkbp:ATCCode |
D05AX52
|
| gptkbp:brand |
gptkb:Enstilar
Taclonex |
| gptkbp:compatibleWith |
face
genitals intertriginous areas |
| gptkbp:contraindication |
hypersensitivity to ingredients
acne vulgaris bacterial skin infections viral skin infections atrophied skin children under 18 years (for some formulations) fungal skin infections perioral dermatitis tuberculous skin lesions ulcerated skin |
| gptkbp:form |
gel
topical ointment |
| https://www.w3.org/2000/01/rdf-schema#label |
Daivobet
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:LEO_Pharma
|
| gptkbp:maximumWeeklyDose |
100g (ointment)
|
| gptkbp:mechanismOfAction |
reduces inflammation and cell proliferation
|
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:riskFactor |
hypercalcemia (if overused)
systemic corticosteroid effects (if overused) |
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:shouldNotBeUsedWith |
other corticosteroids (topical, systemic)
other vitamin D analogues |
| gptkbp:sideEffect |
gptkb:folliculitis
pruritus skin irritation |
| gptkbp:storage |
below 25°C
|
| gptkbp:usedFor |
psoriasis
|
| gptkbp:bfsParent |
gptkb:LEO_Pharma
|
| gptkbp:bfsLayer |
7
|